Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2018-12-04
Buyer: Oslo Universitetssykehus HF — Strategi og anskaffelsesavdelingen MTV
Country: NO
Contract type: Supplies
Procedure: Contract award without prior publication
CPV classification: 33100000
Estimated value: 2118962 NOK
Award criteria: The most economic tender

Technical requirements: Oslo University Hospital, the Children and Youth Clinic, Newborn Screening, the SCID project, will procure a DNA-RNA analyser. The newborn screening annually receives approx. 60 000 blood samples on filter paper from newborns in Norway. DNA is extracted from these cards and used in molecular biological analyses as part of an examination for serious inherited diseases. We would like a flexible and sensitive instrument that can be used to analyse the extracted DNA as regards the amount and quality, as well as quantifying NGS libraries on selected samples. We will analyse everything from a couple of thousand samples upwards, depending on need. At the moment we will not analyse 60 000 samples.
The framework agreement for kits and other consumables (framework agreement 20180139400) lasts as long as the DNA-RNA analyser is in use at Oslo University Hospital or at the trial. The contract will also apply for kits and consumables for the fragment analyser, which will be procured by taking up an option in the MTV project 75012.
— all equipment offered must satisfy all relevant directives and standards. Documentation for this must be enclosed with the tender offer. Such documentation can, for example, be a Declaration of Conformity,
— the instrument must be able to measure gDNA (qualitative and quantitative) with sensitivity down to 50 pg/μl, and able to detect fragments >50 kb,
— the instrument must be able to measure RNA (qualitative and quantitative) accurately down to 5 ng/μl,
— the instrument must be able to measure concentration and quality on the NGS library with a simple procedure (short hands on time) and accurately enough to be able to dilute the library to sequencing without extra analyses,
All equipment offered must satisfy all relevant directives and standards. Documentation for this must be enclosed with the tender offer. Such documentation can, for example, be a declaration of conformity. The instrument must be able to measure gDNA (qualitative and quantitative) with sensitivity down to 50 pg/μl, and able to detect fragments >50 kb. The instrument must be able to measure RNA (qualitative and quantitative) accurately down to 5 ng/μl. The instrument must be able to measure concentration and quality on the NGS library with a simple procedure (short hands on time) and accurately enough to be able to dilute the library to sequencing without extra analyses. The instrument must be able to measure down to 3 bp solution. The instrument must not require a gas connection. The kits size must be maximum 500 samples.
This is based on Kem En Tec Nordic AB being the only supplier that, due to technical reasons, can deliver in accordance with the requirements. The intention notice is pursuant to the public procurement regulations § 21-5. The terms in FOA § 13-4 (2) and 13-1 (5) are deemed to be fulfilled, as well as the value of the full service contract for the instrument´s lifetime.


Winner: Ken En Tec Nordic AB
Award value: 2118962